NEW YORK - January 10, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX).
CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION
If you are a TransMedics investor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.
On January 10, 2025, Scorpion Capital published a short report entitled, “Walk Like An Egyptian: A ‘Mafia-Style’ Extortion, Racketeering, And Organ Trafficking Scheme Masquerading And A Medical Device Company – Fueled By Kickbacks, Billing Fraud, Unreported Device Failures, And Off-Label Misuse On A Vast Scale; Precipitating A Customer Exodus And Rapidly Unfolding Death Spiral. Target Price: $0” (“the Report”). The Report alleges, among other things, fraudulent billing schemes, off-label misuse of its devices, and reliance on kickbacks to drive sales. The Report also alleges that the Company may be under regulatory scrutiny by the U.S. Department of Justice, Internal Revenue Service, and state attorneys general for Medicare fraud linked to organ acquisition costs.
On this news, the price of TransMedics stock fell by $3.74, or 5.16%, to close at $68.81 on January 10, 2025.
WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
If you have any questions about this investigation, please contact:
Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
pmayer@kaplanfox.com
Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
lking@kaplanfox.com
View the original release on www.newmediawire.com
